Verseon Corporation Verseon unveils new blockchain technology (0404B)
18 Septembre 2018 - 8:01AM
UK Regulatory
TIDMVSN
RNS Number : 0404B
Verseon Corporation
18 September 2018
Press release September 18, 2018
Verseon Corporation
("Verseon" or the "Company")
Verseon unveils new blockchain technology
Blockchain initiative will enable medical and pharma companies
to fund and accelerate life-saving developments
Fremont, Calif.-Verseon today unveils transformative blockchain
technology for tokenized securities, developed by its wholly owned
subsidiary, BlockRules Ltd. Since its founding in 2002, Verseon's
mission remains to develop disruptive technologies and products
that advance global health. As part of this goal, the company is
challenging traditional drug development funding models through the
process of tokenization of securities.
BlockRules technology supports the sale, launch, and trading of
securities on a public blockchain complete with multijurisdictional
regulatory compliance integrated and enforced directly on the
blockchain. This breakthrough permits fully regulated, secure, and
transparent support of securities, including decentralized
trading.
Current blockchain technology has the potential to transform the
global investment landscape. To accomplish that, token offerings
need to comply with existing security regulations if they are to
become ubiquitous. The technology developed by BlockRules is
designed to overcome these regulatory hurdles.
"We founded Verseon with the goal of developing new technologies
to advance the discovery and development of new medicines," said
Adityo Prakash, CEO of Verseon. "By democratizing investment access
with blockchain technology, we will change the way new medicines
and other life-science innovations are funded and how the resulting
proceeds are shared."
BlockRules Ltd. plans to offer its technology to innovative
companies ready to embrace the rapidly developing blockchain
community. By bringing regulatory certainty to the blockchain,
BlockRules aims to provide the global investment community with
safer and more relevant opportunities for investment.
"Recent advances in the blockchain space have the potential to
narrow the gap between innovative companies and investors," said
Neil Woodford, founding partner of Woodford Investment Management*.
"Verseon's innovations in this space address some of the
traditional choke points in capital flow and should lead to a more
efficient market."
About BlockRules Ltd.
BlockRules Ltd., a wholly owned subsidiary of Verseon, is a
blockchain technology company supporting the sale, launch and
trading of securities. By enforcing multijurisdictional regulatory
compliance directly on the blockchain, the company facilitates
issuance and decentralized trading that is secure, transparent and
verifiable. BlockRules Ltd. handles the registration of investor
KYC ("know your customer") information for its products and is
providing this service to prospective investors at
https://www.blockrules.com.
About Verseon
Verseon Corporation (www.verseon.com, AIM: VSN) is developing
disruptive life-science technology to advance global health. The
clinical-phase Company is using its proprietary, computational drug
discovery platform paired with a comprehensive in-house chemistry
and biology workflow to build a growing drug development pipeline.
Through its wholly owned subsidiary BlockRules Ltd., Verseon is
also pioneering blockchain technology for regulated securities.
*Woodford Investment Management is a shareholder in Verseon
-Ends-
For further information, please contact
Verseon Corporation www.verseon.com
Sebastian Wykeham +1 (510) 225 9000
Arden Partners (NOMAD and Joint Broker)
+44 (0) 20 7614
Ruari McGirr / Maria Gomez De Olea 5900
Cantor Fitzgerald Europe (Joint Broker)
+44 (0) 20 7894
Marc Milmo / Phil Davies 7000
For financial and business media enquiries, please contact
Buchanan Communications Ltd (PR Advisers)
+44 (0) 20 7466
Henry Harrison-Topham / Jamie Hooper 5000
For trade and pharma media enquiries, please contact
Vane Percy & Roberts
+44 (0) 1737 821
Simon Vane Percy 890
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
MSCLRMLTMBMBBFP
(END) Dow Jones Newswires
September 18, 2018 02:01 ET (06:01 GMT)
Verseon (LSE:VSN)
Graphique Historique de l'Action
De Mai 2024 à Juin 2024
Verseon (LSE:VSN)
Graphique Historique de l'Action
De Juin 2023 à Juin 2024